Company Filing History:
2 out of 259 
2 out of 69 
Years Active: 2006-2021
Title: Innovations of Julian Edward Sale
Introduction
Julian Edward Sale is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that target specific receptors involved in various diseases. With a total of 4 patents, his work has the potential to impact treatments for conditions such as cancer and inflammation.
Latest Patents
Among his latest patents, Sale has developed a nucleic acid encoding an angiopoietin-2 specific Tie2 receptor. This invention includes a polypeptide that binds preferentially to angiopoietin-2 compared to angiopoietin-1. Additionally, he has patented nucleic acid sequences encoding this polypeptide, along with its pharmaceutical applications in treating diseases like cancer and inflammation. Another significant patent is the angiopoietin-2 specific TIE2 receptor, which shares similar characteristics and applications as his previous work.
Career Highlights
Throughout his career, Julian Edward Sale has worked with esteemed organizations such as the Medical Research Council and United Kingdom Research and Innovation. His experience in these institutions has allowed him to collaborate on groundbreaking research and innovations in the field of medical science.
Collaborations
Some of his notable coworkers include Michael S Neuberger and Sarah Jane Cumbers. Their collaborative efforts have contributed to the advancement of research in biotechnology and related fields.
Conclusion
Julian Edward Sale's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments in medicine.